Steven R. Cummings, MD; Warren S. Browner, MD, MPH; Deborah Grady, MD, MPH; Bruce Ettinger, MD
A woman's decision about whether to take hormones after menopause can substantially change her risk for several diseases. A number of prospective studies (1) have found that women who use estrogen have about half the risk for coronary heart disease; because coronary heart disease is by far the leading cause of death among women, this is the most important potential benefit of estrogen therapy. Cancer, on the other hand, is less common than coronary heart disease but more frightening to many women. If used long-term without a progestin, estrogen substantially increases the risk for endometrial cancer (2). If used for
Learn more about subscription options.
Register Now for a free account.
Cummings SR, Browner WS, Grady D, Ettinger B. Should Prescription of Postmenopausal Hormone Therapy Be Based on the Results of Bone Densitometry?. Ann Intern Med. 1990;113:565–567. doi: 10.7326/0003-4819-113-8-565
Download citation file:
Published: Ann Intern Med. 1990;113(8):565-567.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only